Novavax COVID vaccine is nearing approval – but what impact will it have?

The pandemic has been rumbling on for two years and is probably going to rumble on for years to come. And despite recent excitement about new drugs to treat COVID, it’s still vaccines that will underpin each country’s route out of the pandemic.

Calling children ‘vectors’ during COVID-19 is turning into discrimination

During the COVID-19 pandemic children have been the target of dehumanising language and of policy which prioritises the needs of adults over theirs.

How to prepare and protect your gut health over Christmas and the silly season

Gut health matters. Your gut is a crucial part your immune system. In fact, 70% of your entire immune system sits around your gut, and an important part of that is what’s known as the gut-associated lymphoid tissue (GALT), which houses a host of immune cells in your gut.

Why eco-labelling is so difficult during the COVID-19 pandemic

The eco-labels we come to trust are often ones backed by credible audits that involve in-person inspections of production facilities to check that environmental and ethical claims are real.

Latest News

New antidepressants can lift depression and suicidal thoughts fast, but don’t expect magic cures

Depression is the most common cause of disability in the world. Chances are high that you or someone you know will experience a period when depression gets in the way of work, social life or family life. Nearly two in three people with depression will experience severe effects.

U.S. hospital demand for Lilly, Regeneron COVID-19 antibody drugs 'disappointing'

(Reuters) - U.S. hospitals have been slow to embrace COVID-19 antibody drugs from Eli Lilly and Co and Regeneron Pharmaceuticals Inc that have been authorized to reduce the risk of hospitalization, U.S. officials said on Wednesday.

ENHYPEN Smashes Record For Highest First-Week Sales Among 2020 Rookies With 'BORDER: DAY ONE'

ENHYPEN covets a new record for being the highest-charting rookie of this year when it comes to first-week sales with its debut album 'BORDER: DAY ONE.'

top Business stories, straight to your inbox.

Rookie Boy Group ENHYPEN's Debut Album Covets First Spot In Japan Charts

ENHYPEN tops the daily albums chart of Japan's Oricon with its debut album 'BORDER: DAY ONE.'

BTS's 'BE' Sits At No. 2 On Album Charts In Three Of The World's Biggest Music Markets

BTS impresses the global music scene by ranking second on Album Charts in Germany, the United Kingdom, and France.

BTS Update: 'BE' First-Week Sales Smashed Figures

BTS is going strong as the band's newest album 'BE' is on top, again: this time, it's the first-week sales.
1 2 3 4 5 6 7 8 9